Business

Announcement on Wholly-owned Subsidiary Obtaining Notice of Acceptance of Application for Drug Clinical Trial

Announcement on Wholly-owned Subsidiary Obtaining Notice of Acceptance of Application for Drug Clinical Trial

articleVcanbio Cell & Gene Engineering Corp., Ltd. Class AJune 23, 20253/news/announcement-on-wholly-owned-subsidiary-obtaining-notice-of-acceptance-of-application-for-drug-clinical-trial
Announcement on Wholly-owned Subsidiary Obtaining Notice of Acceptance of Application for Drug Clinical Trial

About this update from Vcanbio Cell & Gene Engineering Corp., Ltd. Class A

Announcement on Wholly-owned Subsidiary Obtaining Notice of Acceptance of Application for Drug Clinical TrialThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Vcanbio Cell & Gene Engineering Corp., Ltd. Class A